Aaron Berg Biography and Net Worth

President & CEO of Amarin


Mr. Berg joined Amarin in November 2012 and has over 25 years of life science industry experience. Mr. Berg was initially positioned at Amarin as Vice President, Marketing and Managed Care. He was promoted to Senior Vice President, Marketing and Sales in February 2014, and to the position of Senior Vice President and Chief Commercial Officer in April 2018. He briefly served as the Interim President and CEO in April of 2023 before returning to his position of EVP, President US in July, 2023.

What is Aaron Berg's net worth?

The estimated net worth of Aaron Berg is at least $662.83 thousand as of August 2nd, 2024. Mr. Berg owns 40,269 shares of Amarin stock worth more than $662,828 as of December 5th. This net worth estimate does not reflect any other investments that Mr. Berg may own. Additionally, Mr. Berg receives a salary of $1,260,000.00 as President & CEO at Amarin. Learn More about Aaron Berg's net worth.

How old is Aaron Berg?

Mr. Berg is currently 61 years old. There are 5 older executives and no younger executives at Amarin. Learn More on Aaron Berg's age.

What is Aaron Berg's salary?

As the President & CEO of Amarin Corporation PLC, Mr. Berg earns $1,260,000.00 per year. Learn More on Aaron Berg's salary.

How do I contact Aaron Berg?

The corporate mailing address for Mr. Berg and other Amarin executives is 77 Sir John Rogerson`s Quay Block C Grand Canal Docklands, Dublin L2, Dublin 2. Amarin can also be reached via phone at (531) 669-9020 and via email at [email protected]. Learn More on Aaron Berg's contact information.

Has Aaron Berg been buying or selling shares of Amarin?

Aaron Berg has not been actively trading shares of Amarin during the last quarter. Most recently, on Friday, August 2nd, Aaron Berg bought 8,000 shares of Amarin stock. The stock was acquired at an average cost of $12.80 per share, with a total value of $102,400.00. Following the completion of the transaction, the chief executive officer now directly owns 40,269 shares of the company's stock, valued at $515,443.20. Learn More on Aaron Berg's trading history.

Who are Amarin's active insiders?

Amarin's insider roster includes Aaron Berg (President & CEO), Michael Kalb (CFO), Joseph Kennedy (General Counsel), Steven Ketchum (Insider), David Stack (Director), and Joseph Zakrzewski (Director). Learn More on Amarin's active insiders.

Aaron Berg Insider Trading History at Amarin

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/2/2024Buy8,000$12.80$102,400.0040,269View SEC Filing Icon  
7/3/2019Sell4,940$426.00$2,104,440.00View SEC Filing Icon  
6/24/2019Sell5,659$371.80$2,104,016.20View SEC Filing Icon  
See Full Table

Aaron Berg Buying and Selling Activity at Amarin

This chart shows Aaron Berg's buying and selling at Amarin by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amarin Company Overview

Amarin logo
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, European countries, Canada, Lebanon, and the United Arab Emirates. The company offers VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia. It sells its products principally to wholesalers and specialty pharmacy providers. The company has a collaboration with Mochida Pharmaceutical Co., Ltd. to develop and commercialize drug products and indications based on the active pharmaceutical ingredient in Vascepa. The company was formerly known as Ethical Holdings plc and changed its name to Amarin Corporation plc in 1999. Amarin Corporation plc was incorporated in 1989 and is headquartered in Dublin, Ireland.
Read More

Today's Range

Now: $16.46
Low: $15.69
High: $16.58

50 Day Range

MA: $17.30
Low: $15.20
High: $20.25

2 Week Range

Now: $16.46
Low: $7.08
High: $20.90

Volume

55,382 shs

Average Volume

76,011 shs

Market Capitalization

$342.20 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.71